Retrospective evaluation of the patients with urinary tract infections due to carbapenemase producing Enterobacteriaceae

References

• Cantón R, Akóva M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect off Publ Eur Soc Clin Microbiol Infect Dis. 2012;18:413–431.
   PubMed Web of Science ®Google Scholar
• European Union, European Union bEuropean Centre for Disease Prevention and Control (2012). Antimicrobial resistance surveillance in Europe 2011. Luxembourg, Publications Office of the European Union. Available from: http://ecdc.europa.eu/en/publications-data/antimicrobial-resistance-surveillance-europe-2011. Accessed: 26 February 2019.
   Google Scholar
• Souli M, Galani I, Antoniadou A, Papadomichelakis E, Poulakou G, Panagea T, et al. An outbreak of infection due to β‐lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis. 2010;50:364–373.
   PubMed Web of Science ®Google Scholar
• Bratu S, Landman D, Haag R, Recco R, Eramo A, Alam M, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med. 2005;165:1430–1435.
   PubMed Web of Science ®Google Scholar
• Marchaim D, Navon-Venezia S, Schwaber MJ, Carmeli Y. Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes. Antimicrob Agents Chemother. 2008;52:1413–1418.
   PubMed Web of Science ®Google Scholar
• Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;7:653–660.
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801–810.
   PubMed Web of Science ®Google Scholar
• Tängdén T, Giske CG. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control. J Intern Med. 2015;277:501–512.
   PubMed Web of Science ®Google Scholar
• Yürüyen C, Gürol Y, Kaleağasioğlu SF, Kaspar EÇ, Yilmaz G. Isolation rates and antibiotic susceptibilities of different Enterobacteriaceae species as urinary tract infection agents in Turkey: a systematic review. Turk J Med Sci. 2017;47:979–986.
   PubMed Web of Science ®Google Scholar
• Lesho EP, Clifford RJ, Chukwuma U, Kwak YI, Maneval M, Neumann C, et al. Carbapenem-resistant Enterobacteriaceae and the correlation between carbapenem and fluoroquinolone usage and resistance in the US military health system. Diagn Microbiol Infect Dis. 2015; 81:119–125.
   PubMed Web of Science ®Google Scholar
• Falagas ME, Lourida P, Poulikakos P, Rafailidis PI, Tansarli GS. Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrob Agents Chemother. 2014;58:654–663.
   PubMed Web of Science ®Google Scholar
• Souli M, Karaiskos I, Masgala A, Galani L, Barmpouti E, Giamarellou H. Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae. Eur J Clin Microbiol Infect Dis. 2017;36:1305–1315.
   PubMed Web of Science ®Google Scholar
• Kutlu HH, Us E, Tekeli A. Investigation of carbapenemase genes and molecular epidemiology of Enterobacteriaceae strains isolated between 2010-2014 in a university hospitals. Mikrobiyol Bul. 2018; 52:1–12.
   PubMed Web of Science ®Google Scholar
• Candevir Ulu A, Güven Gökmen T, Kibar F, Kurtaran B, Önlen C, Kuşçu F, et al. Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae at a Turkish centre: Is the increase of resistance a threat for Europe? J Glob Antimicrob Resist. 2017;11:10–16.
   PubMed Web of Science ®Google Scholar
• Albiger B, Glasner C, Struelens MJ, Grundmann H, Monnet DL. EuSCAPE working group. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2015;20(45):pii=30062. doi:10.2807/1560-7917.ES.2015.20.45.30062
   Google Scholar
• Labarca J, Poirel L, Ozdamar M, Turkoglü S, Hakko E, Nordmann P. KPC-producing Klebsiella pneumoniae, finally targeting Turkey. New Microbes New Infect. 2014;2:50–51.
   PubMedGoogle Scholar
• Poirel L, Ozdamar M, Ocampo-Sosa AA, Türkoglu S, Ozer UG, Nordmann P. NDM-1-producing Klebsiella pneumoniae now in Turkey. Antimicrob Agents Chemother. 2012;56:2784–2785.
   PubMed Web of Science ®Google Scholar
• Poirel L, Yilmaz M, Istanbullu A, Arslan F, Mert A, Bernabeu S, et al. Spread of NDM-1-producing Enterobacteriaceae in a neonatal intensive care unit in Istanbul, Turkey. Antimicrob Agents Chemother. 2014;58:2929–2933.
   PubMed Web of Science ®Google Scholar
• Kilic A, Baysallar M. The first Klebsiella pneumoniae isolate co-producing OXA-48 and NDM-1 in Turkey. Ann Lab Med. 2015;35:382–383.
   PubMed Web of Science ®Google Scholar
• Zarakolu P, Aslan AT, Perry J. Evaluation of two commercial assays for the rapid confirmation of OXA-48 like carbapenemases produced by Klebsiella pneumoniae. Turk J Med Sci. 2018;48:679–680.
   PubMed Web of Science ®Google Scholar
• Tekintaş Y, Çilli F, Eraç B, Yaşar M, Aydemir SŞ, Hoşgör Limoncu M. Comparison of phenotypic methods and polymerase chain reaction for the detection of carbapenemase production in clinical Klebsiella pneumoniae isolates. Mikrobiyol Bul. 2017; 51:269–276.
   PubMed Web of Science ®Google Scholar
• Galani I, Nafplioti K, Chatzikonstantinou M, Souli M. In vitro evaluation of double-carbapenem combinations against OXA-48-producing Klebsiella pneumoniae isolates using time-kill studies. J Med Microbiol. 2018;67:662–668. doi:10.1099/jmm.0.00
   PubMed Web of Science ®Google Scholar
• Çilli FF, Arda B, Uyan A, Kayin M, Dikiş D, Korkmaz N, et al. What is the rectal colonization rate of carbapenem-resistant Enterobacteriaceae (CRE)-infected patients? What is the decolonization rate of CRE-colonized patients in the hospital? Turk J Med Sci. 2017; 47:1053–1054.
   PubMed Web of Science ®Google Scholar
• Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014;28:1–13.
   PubMed Web of Science ®Google Scholar
• Gupta K, Trautner BW. Diagnosis and management of recurrent urinary tract infections in non-pregnant women. BMJ. 2013;346:f3140. doi:10.1136/bmj.f3140
   PubMedGoogle Scholar